How China Is Evolving From a Maker of Copycat Medicines Into a Producer of Complex Drugs - WSJ

How China Is Evolving From a Maker of Copycat Medicines Into a Producer of Complex Drugs - WSJ: Johnson & Johnson was impressed enough by Nanjing Legend Biotechnology’s work on an experimental gene therapy that it paid $350 million for the global rights to the cancer treatment.